awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34523319-18C1F408-D94E-4A2E-BC3A-E6DFF57D9F59
Q34523319-18C1F408-D94E-4A2E-BC3A-E6DFF57D9F59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34523319-18C1F408-D94E-4A2E-BC3A-E6DFF57D9F59
Antiangiogenic therapy for glioblastoma: current status and future prospects.
P2860
Q34523319-18C1F408-D94E-4A2E-BC3A-E6DFF57D9F59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34523319-18C1F408-D94E-4A2E-BC3A-E6DFF57D9F59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cac83deb73f7e1d50d026e5c614936bc999a2482
P2860
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients.